• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Histone H2A type 2-A (H2AC18; H2AC19)

ACP16592

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16592 Target NameH2AC18; H2AC19
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-130Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6FI13
Background Information
  • Uniprot Id

    Q6FI13

  • Target Species

    Human

  • Target Name

    H2AC18

  • Target Full Name

    Histone H2A type 2-A

  • Target Function

    Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.

  • Target Subcellular Location

    Nucleus. Chromosome.

  • Target Protein Families

    Histone H2A family

  • Target Research Area

    Cancer

  • Target Synonyms

    H2A histone family; member O; H2A2A_HUMAN; H2aa3; H2aa4; H2AFO; HIST2H2AA; HIST2H2AA3; HIST2H2AA4; histone 2; histone cluster 2; H2aa3 ; Histone H2A type 2-A; Histone H2A.2; Histone H2A/o; histone H2A/r; H2AC18; H2AC19

Inquire Recombinant Human Histone H2A type 2-A (H2AC18; H2AC19) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification